Sign in

Pablo Perez Lopez

@pabloplopez.bsky.social
556 followers 2.2K following 263 posts

🩺 UAM MD Y5 | 👥 Medical Student Leadership ACC | 🫀CNIC Student | 🗞️ SoMe Editor @escardio.bsky.social #CardioSky

PostsRepliesMedia
Pablo Perez Lopez @pabloplopez.bsky.social · 25/06/2026
#EHJCVI🫀Check out the latest Focus Issue on VHD! Featuring sex differences, myocardial function assessment, AR & AS, prognostic value of MAC, prognostic impact of #CMR, RCTs, a new TR grading, GLIDE Score, and much more! ❤️ A must-read 📊 academic.oup.com/ehj... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 17/06/2026
#EHJCVI🫀Keep the foCUS on poCUS in emergency and critical care settings:💡improve outcomes. AI will enhance diagnostic accuracy 🚨Ongoing practice and continuous learning are essential to maintain competence 👉 doi.org/10.1093/ehjc... #poCUS #ESC #echofirst #MedSky
021 0
Pablo Perez Lopez @pabloplopez.bsky.social · 14/06/2026
#EHJCVI 🫀 More cancer survivors = more CV risk focus. Cardiac imaging must be tailored to unique clinical circumstances and individual patient characteristics. Don't overlook PAD in baseline assessments❗ #CardioOncology 👉 doi.org/10.1093/ehjc... #MedSky
010 0
Pablo Perez Lopez @pabloplopez.bsky.social · 10/06/2026
#EHJCVI 🫀| Over 24 years, normal myocardial perfusion imaging scans #CVNuc increased (53% -> 66%) at a Swiss tertiary center. Read more about possible reasons why 👉 doi.org/10.1093/ehjc...
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 04/06/2026
#EHJCVI 🫀| Using vascular deformation mapping on #yesCCT, latent aortic growth in ascending aortic aneurysms may represent an imaging biomarker of diffuse genetic aortopathy. 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 01/06/2026
#EHJCVI 🫀| In type A aortic dissection, CT-FFR #yesCCT may help identify high-risk patients and optimize post-operative management strategies beyond anatomical CCTA assessment. 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 31/05/2026
#EHJCVI 🫀| Does combining abnormal myocardial perfusion reserve and myocardial infarction on #WhyCMR improve risk stratification in type 2 diabetes mellitus? Find out 👉 doi.org/10.1093/ehjc... #MedSky
100 0
Pablo Perez Lopez @pabloplopez.bsky.social · 26/05/2026
#EHJCVI 🫀| Can delayed-phase #yesCCT improve risk stratification? Coexistence of late iodine enhancement and elevated ECV was linked to a 1.84-fold higher hazard of death or unplanned CV hospitalization. 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 25/05/2026
#EHJCVI 🫀Identifying high-risk HCM remains a challenge: should we implement an HCM-LGE score? LGE granularity model (which accounts for extent, septal location, and subepicardial-midwall patterns) demonstrates excellent performance. Read more 👉 doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 24/05/2026
#EHJCVI 🫀QUIZ ‼️ Answer: Fake aortic dissection. This case underscores a critical diagnostic pitfall in CT interpretation in patients on mechanical circulatory support 💔 ECG-gated CT is 🔝 Read more ⏩ doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 23/05/2026
#EHJCVI 🫀 Beyond the mid-wall pattern‼️ #WhyCMR Subendocardial LGE has prognostic implications in NICM ⚡️Scar phenotyping enhances arrhythmic risk stratification and helps bridge the gap between risk prediction and effective prevention of #SCD ⏩ doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 21/05/2026
#EHJCVI 🫀 A paradigm shift in endomyocardial biopsy? #WhyCMR LGE can be transformed into a patient-specific 3D roadmap to guide biopsy 💉 Targeted EMB directly impact therapeutic decision-making, including immunosuppressive treatment ❤️‍🔥 Read more ⏩ doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 20/05/2026
#EHJCVI 🫀QUIZ ‼️ 50-year-old with cardiogenic shock 💔 Combined circulatory support with Impella 5.5 and VA-ECMO was needed. Both successfully weaned on Day 12 ✅ Day 16: sudden circulatory collapse⏩ re-initiation VA-ECMO 🚨 #CTAngio after cardiac arrest revealed…
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 17/05/2026
#EHJCVI 🫀Combining information on carotid plaque calcification and inflammation is 🔑 [68Ga]DOTA-TOC PET/CT carotid uptake 💡 identifies patients with high risk of cardio-cerebrovascular adverse outcomes 🚨 #NuclearCardiology. Read more ⏩️ doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 14/05/2026
#EHJCVI 🔎 Moderate + moderate ≠ low risk. In multivalvular disease, combined lesions can behave like severe disease 📊 Cumulative burden should be central to risk assessment #VHD. Read more here: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 13/05/2026
#EHJCVI 🔍🧬 Lp(a) selectively tracks vulnerability. In asymptomatic patients, it was independently associated with high-risk, low-density non-calcified plaque on AI-CCTA, while CAC reflected overall plaque burden 📊 Curious to dive deeper? 👉 Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 12/05/2026
#EHJCVI ‼️ LDL-C <55 mg/dL is guideline-recommended, with potential variation in benefit by plaque phenotype. In REASSURE-NIRS, NIRS-derived lipid-rich plaques were associated with greater event reduction 👉 Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 10/05/2026
#EHJCVI 🫀❓Beyond anatomy in chronic coronary disease: does function matter? In ISCHEMIA, peak METs 🏃‍♂️ provided incremental prognostic value beyond CCTA. 💡 A more integrated approach to risk assessment may be needed. ⏩ Read more: doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 06/05/2026
#EHJCVI 🔍 What if calcium, not just anatomy, drives success in percutaneous mitral commissurotomy? In CALCIMIT, CT-derived MVCS predicted outcomes. ⚡ Time to integrate quantification? 👉 Find out more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 05/05/2026
#EHJCVI 🫀🧲 Same initial infarct area, different recovery 💡 In 672 first-time #STEMI patients, 🚭 quitting smoking was linked to greater infarct size reduction on #whyCMR and fewer MACE ‼️⏩Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 04/05/2026
🚀 Want to stay updated with the latest from #EHJCVI? 📲 Don’t miss out on cutting-edge imaging, key papers, and expert insights shaping cardiovascular medicine 👥 Follow our Social Media Editors and stay one step ahead #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 03/05/2026
#EHJCVI 🫀🧠 Beyond LA volume in cryptogenic stroke? 🔍 LA strain and sphericity on #echofirst independently predicted recurrent stroke and new #AFib in ESUS ‼️ ⏩Read more: doi.org/10.1093/ehjc... #MedSky
010 0
Pablo Perez Lopez @pabloplopez.bsky.social · 02/05/2026
#EHJCVI 🫀 Time to refine #echofirst quantification of aortic regurgitation? 🔍 Using #whyCMR as reference, a 2-step TTE algorithm (RegVol≥45 mL + LVEDVi≥93 mL/m²) outperformed traditional criteria for severe AR definition‼️ #VHD ⏩Read more: doi.org/10.1093/ehjc... #MedSky
211 0
Pablo Perez Lopez @pabloplopez.bsky.social · 30/04/2026
#EHJCVI 🫀 LA strain by #whyCMR refines risk stratification in #HCM with low SCD risk 💡 LVEF>50% + LGE<5% + LA-GLS>37.6% identified an ultra-low-risk subgroup with MACE rate of just 2% ‼️ ⏩ Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 28/04/2026
#EHJCVI 🫀 🔍 Should stage 3-4 cardiac damage flag futility in #TAVI? In the COMPARE-TAVI 1 sub-study (n=985), all CD stages benefited from TAVI, with similar 1-year futility (death/NYHA 3-4) across groups ‼️ #echofirst #VHD ⏩ Read more: doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 22/04/2026
#EHJCVI 📊🧠 In CCTA, risk evolves over time. Stenosis severity predicts short-term events, while plaque burden (PAV) drives long-term outcomes, highlighting the dynamic nature of CAD risk #YesCCT 🔗 Read more -> doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 18/04/2026
#EHJCVI ⚠️ CMR staging after STEMI matters 📈 Higher CCS stages of myocardial injury predict worse 1-year outcomes, stage 4 carries the highest risk of MACE and mortality. #WhyCMR 🔗 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 16/04/2026
#EHJCVI 🧲📊 DANAMI-3: ↓ infarct size/transmurality and ↑ myocardial salvage index/LVEF (at acute + 3 months) were associated with lower 10-year mortality/HF hospitalization, while microvascular obstruction was not #WhyCMR 🔗 Read more -> doi.org/10.1093/ehjc... #MedSky
010 0
Pablo Perez Lopez @pabloplopez.bsky.social · 12/04/2026
#EHJCVI🫀QUIZ‼️A 14-year-old presents with chest pain, elevated troponin, LV dysfunction, and normal coronaries on CTA. MRI shows myocardial injury and an incidental adrenal mass❓ What is the most likely underlying cause? #MedSky
100 0
Pablo Perez Lopez @pabloplopez.bsky.social · 11/04/2026
#EHJCVI 🔍 New insights into PFO risk. Totaro et al. identify “funnel-type” PFO morphology on 3D-TEE as a novel high-risk feature 🧠📊 Read more 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 09/04/2026
#EHJCVI 🏎️🧲 Stress CMR in the fast lane. This editorial explores its role in detecting significant CAD, along with key implications and remaining knowledge gaps 🫀📊 Read more 👉 doi.org/10.1093/ehjc... #MedSky
010 0
Pablo Perez Lopez @pabloplopez.bsky.social · 08/04/2026
#EHJCVI 🧲 MRI reveals what wall thickness alone can miss 📏 Wall Thickness SD (WTSD) identifies both overt and early hypertrophic cardiomyopathy, even before hypertrophy is evident 🔍✨Read more 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 05/04/2026
#EHJCVI🫀QUIZ‼️A 70-year-old woman with palpitations and labile blood pressure. Holter ECG shows one run of monomorphic NSVT. History of asthma, hypercholesterolemia, and Barlow’s disease. Referred for TEE during cardio-oncologic surveillance 👉 What’s your diagnosis?
100 0
Pablo Perez Lopez @pabloplopez.bsky.social · 04/04/2026
#EHJCVI 🫀Stress imaging guides decision-making in paediatric cardiology. Modality choice should reflect expertise, efficacy, limitations, and safety. This study provides a practical framework across multiple clinical scenarios 🧭 Read more 👉 doi.org/10.1093/ehjc... #Medsky
001 0
Pablo Perez Lopez @pabloplopez.bsky.social · 03/04/2026
#EHJCVI 📉 PR prevalence may be underestimated due suboptimal assessment. CMR is gold standard for dx and follow-up, as patients often remain asymptomatic until RV dysfunction. Mortality varies by aetiology, with no increase in idiopathic PR or PH 🔍 👉 doi.org/10.1093/ehjc... #Medsky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 31/03/2026
#EHJCVI 📏 MAD is common in pediatric MFS and links to aortic root dilation. Both #Echofirst and #whyCMR provide reliable assessment. MAD should be routinely evaluated from childhood, with potential as a biomarker of disease progression 🔍🧬 Read more 👉 doi.org/10.1093/ehjc... #MedSky
021 0
Pablo Perez Lopez @pabloplopez.bsky.social · 30/03/2026
#EHJCVI 🫀 Vegetation size influences indication and timing for surgery in current IE guidelines (IIb recommendation if >10 mm). In a large 🇪🇸 registry, large vegetations were associated with ⬆️ embolic events and mortality ‼️ Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 29/03/2026
#EHJCVI 📢 #HowTo paper on intracardiac #echofirst ‼️ ICE is a game changer in TAVI, yet still underused. Its use may reduce post-TAVI conduction disturbances ⚡️ This practical paper provides tips and methods for the use of ICE in guiding TAVI ⏭️doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 28/03/2026
#EHJCVI 🫀 Multimodality imaging is key in cardiac tumours ‼️ This rare case highlights the complementary role of #echofirst, #CVNuclear and #whyCMR in diagnosing and managing a primary cardiac granular cell tumour ⏭️ doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 27/03/2026
#EHJCVI 🫀 Mixed aortic disease is a hemodynamic challenge and an #echofirst dilemma! In this large Korean cohort, moderate aortic stenosis + regurgitation carried a risk of cardiac death and HF hospitalization comparable to severe AS ‼️ Read more: doi.org/10.1093/ehjc... #MedSky
021 0
Pablo Perez Lopez @pabloplopez.bsky.social · 26/03/2026
#EHJCVI There may be something worse than a broken heart! 💔In #Takotsubo syndrome, physical triggers were linked to worse in-hospital and post-discharge outcomes than emotional ones ‼️ Interestingly, PT showed less LGE and lower troponin 💡 Explore: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 25/03/2026
#EHJCVI 📢 New #EACVI & @ASE360 Consensus Statement on Strain Echo🚨 Strain has moved from the research arena into everyday #echofirst clinical practice. A practical guide for clinical echocardiographers, with clear supporting evidence for its use ⏭️ doi.org/10.1093/ehjc... #MedSky
012 0
Pablo Perez Lopez @pabloplopez.bsky.social · 25/03/2026
#EHJCVI 🫀 Scar is more than just the presence of LGE on #WhyCMR 💡 In this study with >400 #HCM patients, scar composition and border-zone channels predicted arrhythmic events and improved ESC and AHA/ACC risk models ‼️ Read more: doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 20/03/2026
#EHJCVI 🫀 Is air pollution linked to early myocardial remodelling? PM2.5 and PM10 are associated with increased ECV after adjustment, with the strongest associations in men and patients >50 years, and no mediation by inflammatory markers 📊🔬 Read more 👉 doi.org/10.1093/ehjc... #MedSky
010 0
Pablo Perez Lopez @pabloplopez.bsky.social · 19/03/2026
#EHJCVI ⏱️ Can left atrial transit time (LATT) predict adverse outcomes? LATT closely correlates with LVEDP and helps estimate it; pLVEDP >13 and >18 are independent risk thresholds, with HR 2.10 and 4.33, respectively 📊⚠️ Read more 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 18/03/2026
#EHJCVI 📏 Should we use sex-specific thresholds for LV hypertrophy in Fabry disease? LVMWT >10 mm in women and >13 mm in men are independently associated with mortality, hospitalization, AF, major arrhythmias, and stroke ⚖️📊 👉 doi.org/10.1093/ehjc... #MedSky
000 0
Pablo Perez Lopez @pabloplopez.bsky.social · 17/03/2026
#EHJCVI 📐🔎 Should we assess RV hemisphericity and hemiconicity angle? These 3D shape-based metrics vary by pathology, sex, and age, and carry strong prognostic implications in atrial secondary TR, adding a new layer to RV evaluation 🧭✨Read more 👉 doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 16/03/2026
#EHJCVI 🫀 Can LA parameters help risk-stratify embolic stroke of undetermined source? Patients show larger LA volumes, reduced reservoir and contractile strain, and increased LA circularity, features suggesting atrial cardiomyopathy may play a role 🔍 👉 doi.org/10.1093/ehjc... #MedSky
011 0
Pablo Perez Lopez @pabloplopez.bsky.social · 24/02/2026
#EHJCVI🫀How do sex and valve morphology shape AS severity? In fibrotic vs calcific remodeling, calcification shows the strongest association with severity, while fibrosis may represent a distinct phenotype more prominent in women with BAV 🔍 👉 doi.org/10.1093/ehjc... #MedSky
051 0
Pablo Perez Lopez @pabloplopez.bsky.social · 23/02/2026
#EHJCVI 🫀Too old or too sick for TAVI? When should we consider futility in advanced AS? This editorial explores whether advanced cardiac damage helps identify patients unlikely to benefit from TAVI and where the line should be drawn 🔍 Read more 👉 doi.org/10.1093/ehjc... #MedSky
031 0